TRCT
RXII

Tower Research Capital (TRC)’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Tower Research Capital (TRC)’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-27,293
Closed -$13K – 5250
2016
Q2 		$13K Buy
+27,293
New +$13K ﹤0.01% 2631
2016
Q1 		– Sell
-10,866
Closed -$16K – 5738
2015
Q4 		$16K Buy
+10,866
New +$16K ﹤0.01% 1582
2015
Q2 		– Sell
-33,327
Closed -$46K – 5739
2015
Q1 		$46K Buy
+33,327
New +$46K 0.01% 1551
2014
Q4 		– Sell
-21,897
Closed -$45K – 5516
2014
Q3 		$45K Buy
+21,897
New +$45K 0.01% 1631
2014
Q2 		– Sell
-400
Closed -$1K – 5442
2014
Q1 		$1K Buy
+400
New +$1K ﹤0.01% 4362
2013
Q4 		– Sell
-825
Closed -$2K – 5487
2013
Q3 		$2K Buy
+825
New +$2K ﹤0.01% 4238

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return